Fidelity Investments
BDSX icon

Fidelity Investments’s Biodesix BDSX Stock Holding History

Fidelity Investments’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15K Buy
95
+94
+9,400% +$1.39K ﹤0.01% 5141
2026
Q1 		$15 Hold
1
– – ﹤0.01% 5366
2025
Q4 		$7 Hold
1
– – ﹤0.01% 5381
2025
Q3 		$8 Hold
1
– – ﹤0.01% 5338
2025
Q2 		$8 Hold
1
– – ﹤0.01% 5294
2025
Q1 		$17 Buy
+1
New +$19 ﹤0.01% 5228
2022
Q3 		– Sell
-13
Closed – – 4853
2022
Q2 		$0 Buy
13
+2
+18% +$65 ﹤0.01% 4915
2022
Q1 		$0 Buy
+11
New +$719 ﹤0.01% 4952

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Fidelity Investments's BDSX Position: Q2 2026 in Review

Fidelity Investments increased its Biodesix (BDSX) stake by 9,400% in Q2 2026, buying an estimated $1.39K and bringing the position to 95 shares worth $2.15K. The position accounts for ﹤0.01% of the portfolio, ranked #5141.

Fidelity Investments first reported a position in BDSX in Q1 2022 and has held it in 8 quarters since. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Fidelity Investments held 95 shares of Biodesix worth $2.15K as of Q2 2026.
  • Fidelity Investments bought 94 Biodesix shares in Q2 2026, an estimated $1.39K.
  • Biodesix made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5141 holding.
  • Fidelity Investments first reported a position in Biodesix in Q1 2022 and has held it in 8 quarters since.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.